Your browser doesn't support javascript.
loading
Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
Lunemann, Sebastian; Schöbel, Anja; Kah, Janine; Fittje, Pia; Hölzemer, Angelique; Langeneckert, Annika E; Hess, Leonard U; Poch, Tobias; Martrus, Gloria; Garcia-Beltran, Wilfredo F; Körner, Christian; Ziegler, Annerose E; Richert, Laura; Oldhafer, Karl J; Schulze Zur Wiesch, Julian; Schramm, Christoph; Dandri, Maura; Herker, Eva; Altfeld, Marcus.
Affiliation
  • Lunemann S; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Schöbel A; Junior Research Group HCV Replication, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Kah J; I. Department of Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fittje P; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Hölzemer A; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; I. Department of Medicine, Section Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner site Ha
  • Langeneckert AE; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Hess LU; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Poch T; I. Department of Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Martrus G; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
  • Garcia-Beltran WF; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts.
  • Körner C; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Ziegler AE; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Richert L; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; INSERM U1219, INRIA SISTM, Bordeaux University, Bordeaux, France.
  • Oldhafer KJ; Department of General and Abdominal Surgery, Asklepios Hospital Barmbek, Semmelweis University of Medicine, Asklepios Campus, Hamburg, Germany.
  • Schulze Zur Wiesch J; I. Department of Medicine, Section Infectious Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schramm C; I. Department of Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Dandri M; I. Department of Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Herker E; Junior Research Group HCV Replication, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Altfeld M; Department of Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany; Institute for Immunology, University Medical Center Hamburg-Eppendorf, Ha
Gastroenterology ; 155(5): 1366-1371.e3, 2018 11.
Article in En | MEDLINE | ID: mdl-30031767
Killer-cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer (NK) cells. Binding of KIR3DS1 to its recently discovered ligand, HLA-F, activates NK cells and has been associated with resolution of hepatitis C virus (HCV) infection. We investigated the mechanisms by which KIR3DS1 contributes to the antiviral immune response. Using cell culture systems, mice with humanized livers, and primary liver tissue from HCV-infected individuals, we found that the KIR3DS1 ligand HLA-F is up-regulated on HCV-infected cells, and that interactions between KIR3DS1 and HLA-F contribute to NK cell-mediated control of HCV. Strategies to promote interaction between KIR3DS1 and HLA-F might be developed for treatment of infectious diseases and cancer.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Killer Cells, Natural / Lymphocyte Activation / Histocompatibility Antigens Class I / Hepacivirus / Receptors, KIR3DS1 Limits: Humans Language: En Journal: Gastroenterology Year: 2018 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Virus Replication / Killer Cells, Natural / Lymphocyte Activation / Histocompatibility Antigens Class I / Hepacivirus / Receptors, KIR3DS1 Limits: Humans Language: En Journal: Gastroenterology Year: 2018 Type: Article Affiliation country: Germany